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Abstract
Transgenes flanked by loxP sites have been widely used to generate transgenic mice where the transgene expression can
be controlled spatially and temporally by Cre recombinase. Data from this approach has led to important conclusions in
cancer, neurodevelopment and neurodegeneration. Using this approach to conditionally express micro RNAs (miRNAs) in
mice, we found that Cre-mediated recombination in neural progenitor cells caused microcephaly in five of our ten
independent transgenic lines. This effect was not associated with the types or the quantity of miRNAs being expressed, nor
was it associated with specific target knockdown. Rather, it was correlated with the presence of multiple tandem transgene
copies and inverted (head-to-head or tail-to-tail) transgene repeats. The presence of these inverted repeats caused a high
level of cell death in the ventricular zone of the embryonic brain, where Cre was expressed. Therefore, results from this Cre-
loxP approach to generate inducible transgenic alleles must be interpreted with caution and conclusions drawn in previous
reports may need reexamination.
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Introduction
The Cre-loxP system has been used widely for conditional
transgene expression in mice. A common approach is to make
transgenic mice by pronuclear injection of transgene constructs
where the transgene is flanked with loxP sites. This approach has
been adopted for either conditional induction or cessation of
transgene expression in a spatially and temporally controllable
manner by crossing with various Cre-expressing driver lines. Since
its first demonstration in mice in 1992 [1,2], this approach has
been used to conditionally express toxic genes for cell ablation
[3,4,5], short hairpin RNAs (shRNAs) for gene silencing [6,7],
disease-associated genes for defining their roles in neurodegener-
ative disorders [8,9,10,11,12] and marker proteins for labeling
different cell populations in the central nervous system (CNS)
[13,14]. To take advantage of this powerful approach, we applied
it for conditional expression of several miRNAs targeting specific
genes in mice.
Results
We used the previously characterized construct pCAG-EGFP/
RFP-miRNAint (G/R-miRNA) to express miRNAs in transgenic
mice (Fig. 1A) [15]. This construct first expresses enhance green
fluorescent protein (EGFP), which enables rapid screen of
transgenic mouse lines where the transgene is active in the desired
tissue. Upon induction by Cre, the EGFP gene is excised, leaving
the promoter to drive the expression of red fluorescent protein
(RFP) and miRNA. The RFP provides a convenient indicator for
the level and location of the miRNA expression [15]. We targeted
two genes with this construct. One was the progranulin gene and
the other was the E1k subunit of a ´-ketoglutarate dehydrogenase
complex (KGDHC). Both genes are involved in neurodegenerative
diseases. Loss of function mutations in the progranulin gene cause
frontotemporal dementia (FTD) and a decrease in KGDHC
activity is associated with Alzheimer’s disease (AD) [16,17,18]. As
a control for possible non-specific effects associated with the
overexpression of miRNA, we used a construct that expresses a
scrambled miRNA (miR-Scr) that does not target any specific
gene.
Transgenic mice were generated by pronuclear injection. Two
constructs for progranulin knockdown (miR-PGRN1 and 9), one
construct for E1k knockdown (miR-E1k) and one construct with
scrambled miRNA sequence (miR-Scr) were injected. Transgenic
lines were screened based on a semi-quantitative estimation of
EGFP fluorescence in the brain. One transgenic line from each of
the two miR-PGRN constructs, two lines from the miR-E1k and
six lines from the miR-Scr were selected and propagated based on
their relatively high levels of EGFP expression in the brain
(Table 1). The transgenes were inherited at a frequency expected
from Mendelian inheritance without any overt phenotypes. To
investigate the effect of PGRN and E1k knockdown in the brain,
we crossed the offspring of these lines with nestin-Cre driver mice,
which express Cre in neural progenitor and glial cells beginning at
,E10.5 day [19]. In half of the transgenic lines, the double
transgenic progeny developed microcephaly. The brains of these
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e18778double transgenic mice (Dtg) weighed approximately 50% of those
of their single transgenic (Stg) and wild type (Wt) littermates
(Fig. 1B; Table 1). The overall brain structures were maintained
but were proportionally smaller than those of the Stg and Wt
littermates. For example, the cortical cell layers appeared normal
but thinner (Fig. 1C). Similarly, the hippocampal architecture
appeared intact but smaller compared with the non-transgenic
brains (Fig. 1D). The microcephaly phenotype was observable at
birth. However, in most lines the number of the double transgenic
progeny was not different from what was expected from
Mendelian inheritance (Table 2), indicating that the microcephaly
did not cause embryonic lethality in most lines.
The microcephaly might be caused by the knockdown of PGRN
or E1k expression, but this appeared unlikely. In the miR-PGRN9
line which had microcephaly, there was only ,25% knockdown of
PGRN mRNA (Table 1). This is unlikely to cause microcephaly
because this phenotype was not observed in the progranulin
knockout mice [20,21,22,23]. In the miR-E1k lines, line 32
developed microcephaly but line 15 did not. However, line 32 had
only ,20% knockdown of the E1k mRNA whereas line 15 had
,75% knockdown. Thus, target knockdown could not explain the
cause of microcephaly.
It has been shown that high levels of siRNA or shRNA
expression can cause toxicity in mice [24,25]. Therefore, high
levels of miRNA expression might also be toxic and cause
microcephaly. To test this possibility, we first analyzed the RFP
expression in the double transgenic progeny since the RFP
expression was driven by the same promoter that drove expression
of the miRNA (Fig. 1A). We found that the levels of RFP did not
correlate with the microcephaly phenotype. For example, the
transgenic lines with the highest RFP levels, such as miR-E1k15,
miR-Scr105, miR-Scr109 and miR-Scr113, did not develop
microcephaly, whereas the lines with low levels of RFP expression,
such as miR-E1k32 and miR-Scr103, developed microcephaly
(Table 1). To verify the miRNA levels, we measured the transgene-
encoded miRNAs by real time RT-PCR and confirmed that most
transgenic lines with the highest miRNA levels did not develop
microcephaly, whereas the lines with relatively low levels of
miRNA did (Table 1). Some transgenic lines also had a significant
level of leakage in miRNA expression before crossing with nestin-
Cre (Table 1), but none showed microcephaly during line
propagation in crossings with the wild type mice. Thus, the
microcephaly phenotype did not correlate with high levels of
miRNA expression.
To further seek the cause for this phenotype, we measured the
transgene copy numbers in all the transgenic lines using real time
PCR of the genomic DNA. Interestingly, four out of five
transgenic lines with microcephaly phenotype had high transgene
copy numbers, while all lines without microcephaly had low
transgene copy numbers (Table 1). This observation raised the
possibility that aberrant Cre-mediated recombination at the site of
the multiple transgene integration might cause the microcephaly.
One possible scenario is that a cellular toxicity might be derived
from the presence of inverted loxP sites, i.e. loxP sites in a head-to-
head or tail-to-tail configuration. For example, transgenes with
inverted loxP repeats can cause chromosome loss and death of
proliferating cells during Cre-mediated recombination [26,27].
However, the prevalent assumption has been that multiple
transgene copies are integrated in a tandem head-to-tail array
with only rare exceptions of inverted repeats [28,29,30].
To test the hypothesis that Cre-mediated recombination of the
loxP-containing transgenes that are integrated in an inverted
Figure 1. Cre-loxP-based conditional miRNA expression causes microcephaly. (A) Schematic diagram of the conditional miRNA expression
strategy. This construct initially expresses EGFP driven by the CAG promoter. After Cre-mediated DNA recombination between two loxP sites, the
loxP-flanked EGFP gene is excised, allowing the promoter to drive the expression of the marker RFP and the miRNA that silences its target gene. pA
stands for polyA signal. (B) Brains from the miRNA and nestin-Cre double transgenic mice (Dtg) are smaller than those of the single transgenic (Stg) or
wild type (Wt) littermates. (C) Hematoxylin and eosin (H&E) stained sagittal sections from of the brains of 21-day-old Dtg (miR-E1k32/nestin-Cre) and
Wt mice. The boundaries of the cortex are marked by dotted lines. Scale bar=200 mm.
doi:10.1371/journal.pone.0018778.g001
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possible types of transgene-transgene junctions, including the
head-to-tail and the inverted head-to-head and tail-to-tail
junctions. We detected head-to-tail PCR products from six out
of ten transgenic lines (Fig. 2; Table 1). Four of these six lines
(miR-PGRN9, miR-E1k32, miR-Scr103 and 97) had 9 or more
transgene copies and also carried inverted transgene integration.
The other two lines (miR-E1k15 and miR-Scr109) had only head-
to-tail integration and carried 2–3 transgene copies. One line miR-
Scr35 carried two transgene copies that are integrated head-to-
head. Three lines (miR-PGRN1, miR-Scr105 and 113) had low
transgene copies and no junctional PCR products. These lines
were likely to carry a single copy of the transgene. To ascertain
that the PCR products are truly derived from the expected
junctions, we sequenced the junctional PCR products and were
able to obtain sequences from most of these fragments (Fig. 2;
Table 1). Because of the frequent deletion of the sequences from
the original constructs at the junctions, we often observed multiple
sequences from one PCR band (Fig. 2). We were able to read
sequences from some of the PCR bands that contained two
sequences, but were unable to read sequences from several other
bands. This was most likely due to the presence of multiple
sequences within those bands.
Notably, all the lines that were positive for the inverted
transgene integration, including miR-pgrn9, -miR-E1k32, miR-
Scr103, miR-Scr97 and miR-Scr35, had the microcephaly
phenotype. In contrast, all the lines that were negative for the
inverted transgene integration did not have the microcephaly
phenotype. Thus, the presence of the inverted transgene
integration predicted the microcephaly. Additionally, of the seven
lines that had two or more copies of the transgene, five had
inverted transgene integration. The two lines that did not have
inverted transgenes had low transgene copies. Thus, contrary to
the prevailing assumption that the transgenes are integrated into
the genome in a head-to-tail tandem array with rare exceptions
[28,29,30], the inverted transgene integration is common in mice
that have multiple transgene copies.
Finally, to determine whether the inverted transgene repeats
caused cell death in proliferating cells, as has been shown
previously [27], we examined the double transgenic embryos with
both the G/R-miRNA and nestin-Cre transgene. We detected
increased cell death in the ventricular zone and the cortex during
the neurogenesis at 14.5 and 16.5 days post coitum (dpc) (Fig. 3).
This observation confirms that the inverted transgene repeats
containing loxP sites caused death of the proliferating cells during
neurogenesis, which led to the microcephaly.
Discussion
While applying the Cre-loxP system for conditional expression of
miRNA in mice, we found a common phenotype of microcephaly
Table 1. Summary of basic characteristics of the ten transgenic lines.
Tg line G/R-miR-PGRN G/R-miR-E1k G/R-miR-Scr
9 1 32 15 103 35 97 105 109 113
GFP (Stg) ++++ +++ ++++ ++++ +++ ++++ ++++ ++++ +++++ +++++
Br wgt (Dtg/Wt) 0.44 0.98 0.55 0.97 0.41 0.51 0.54 0.93 1.01 1.1
RFP (Dtg) ++ + 2 +++ 2 ++ + +++ +++ +++
mRNA (Stg%Wt) 86616 9667.6 10163.5 91610 NA NA NA NA NA NA
mRNA (Dtg%Wt) 7664.7 10066.3 78.566.2 23610 NA NA NA NA NA NA
miRNA (Stg/Wt) 742 301 189 510 948 ND 3295 ND 6838 5082
miRNA (Dtg/Wt) 2381 568 92 1960 130 ND 2272 ND 8352 6803
Tg copy # 28.467.6 0.760.1 9.461.8 2.360.1 21.165.2 1.660.3 15.965.7 1.560.1 1.560.1 1.360.1
H-H junction +* 2 + 2 ++ * 22 2 2
T-T junction +* 22 2+* 2 + 222
H-T junction + 2 +* +* +* 2 +* 2 +* 2
The GFP and RFP fluorescence intensity in the brain was examined under the fluorescent microscope and different intensities of the fluorescence were graded from the
weakest ‘‘+’’ to the strongest ‘‘+++++’’. The brain weights are expressed as ratios of the average from double transgenic mice to that of the age-matched wild type mice.
The average weights with standard deviations and the statistics are shown in Table S1. The levels of mRNA and miRNA were determined by real-time RT-PCR. The mRNA
levels of the double transgenic mice are presented as a percentage of the wild type mice. The miRNA levels of the double transgenic mice are presented as fold
increases over the background value obtained from wild typemice. The transgene copy numbers were determined by real-time PCR of the genomic DNA from single
transgenic miRNA lines. The different types of junctional fragments were detected by PCR using specific primer pairs (see Table 3). Stg: single transgenic mice positive
for the G/R-miRNA transgene only.Dtg: double transgenic mice positive for both the G/R-miRNA transgene and nestin-Cre. Wt: non-transgenic mice. Br: brain. Wgt:
weight ratio of Dtg-to-Wt. Stg%Wt: level in Stg as a percent of Wt. Dtg%Wt: level in Dtg as a percent of Wt. Tg: transgenic. H-T: head-to-tail.H-H: head-to-head. T-T:tail-
to-tail. ‘‘+’’ indicates positive for the specific junctional PCR product. ‘‘2’’ indicates negative for the specific junctional PCR product. ‘‘+*’’ indicates that this PCR product
sequence was successfully read (see Fig. 2).
doi:10.1371/journal.pone.0018778.t001
Table 2. Genotype composition of the progenies from the
crossings of G/R-miRNA and nestin-cre.
Tg Line
miR-
PGRN9
miR-
E1k32
miR-
Scr103
miR-
Scr35
miR-
Scr113
Dtg mice 13 3 13 19 18
Stg mice 44 4 11 18 14
Wt 43 11 13 22 12
nestin-Cre 39 7 10 25 15
total 139 25 47 84 59
P value 0.003 0.856 0.464 0.867 0.957
Genotype composition of the progenies from the crossings of G/R-miRNA and
nestin-Cre. The number of the various genotypes was compared with the
Mendelian ratio using the Chi Square test to obtain the P value.
doi:10.1371/journal.pone.0018778.t002
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phenotype was not correlated with the target gene knockdown or
the levels of miRNA expression. Rather it was correlated with the
integration of inverted transgene copies in the genome. Examina-
tion of mouse embryos showed that Cre-mediated recombination in
the developing brain caused an increase in cell death. Based on
these lines ofevidence, togetherwithprevious studies demonstrating
that Cre-mediated recombination in cells with inverted loxP sites in
the genome can cause chromosome loss and death of proliferating
cells [26,27], we conclude that integration of inverted transgene
repeats into the genome is common in transgenic mice made from
pronuclear injection. If the transgene contains loxP sites, the
inversion can cause death of proliferating cells during Cre-mediated
transgene recombination. In the developing brain, this leads to
microcephaly.
Our finding explains some of the previous observations in the
literature. For example, Lobe and colleagues reported construction
of Cre reporter mice using the construct Z/AP [31], which we
modified in the current study to generate the G/R-miRNA
construct. In the Z/AP construct, the CAG promoter drives the
expression of LacZ gene that is flanked by loxP sites. Upon Cre-
mediated recombination, the LacZ gene is removed and the CAG
promoter drives the expression of the alkaline phosphatase gene.
Among the Z/AP transgenic lines that were crossed with CMV-
Cre driver (a ubiquitous driver), they obtained the expected
induction pattern in a line with a single copy of the transgene.
However, they could not obtain any double transgenic offspring in
a line with multiple transgene copies. In a later report where
another Cre reporter transgenic line was generated, the authors
screened for and used only ES cell clones with a single transgene
copy for generation of the mice [32]. Based on our findings, it is
likely that the transgenic line with multiple transgene copies had
inverted transgene integration, which caused death of double
transgenic embryos.
It has been well-established that inverted loxP sites can cause
chromosome deletion during Cre-mediated recombination in
dividing cells. Lewandoski and Martin first described a transgenic
line that had an inverted loxP-containing transgene on the Y
chromosome. Cre-mediated recombination led to the loss of the Y
chromosome [26]. Later studies took advantage of this phenom-
enon and targeted the inverted loxP sites to specific chromosomes
for induction of chromosome deletion as well as various other
chromosome rearrangements [33,34,35,36]. Furthermore, it has
been shown that Cre-mediated recombination of inverted loxP
sites on autosomes can cause cell death in proliferating cells,
although non-proliferating cells such as neurons are spared
[27,36].
Although the presence of inverted transgenes was found in mice
generated by pronuclear injection in 1980s, it has been thought to
occur rarely [28,29,30]. This has become the basic assumption
Figure 2. Detection of inverted transgene arrays in transgenic lines. (A) PCR products of tail-to-tail, head-to-head and head-to-tail junctions
in seven out of ten transgenic lines (see Table 1). DNA samples from different transgenic mouse lines are shown in each lane. The positions of the
primers are indicated in (B) and their sequences are shown in Table 3. (B) Sequences were successfully read from some of the PCR bands shown in (A)
and these bands are marked with numbers in the parentheses. Some bands contain two sequences that can be read and these are marked by two
numbers in the parentheses. The bands without sequences represent those that could not be read, most likely due to multiple sequences in the
band. NC is a control in the PCR reaction using the DNA from a non-transgenic mouse. Sequences obtained from the numbered bands are aligned
with the expected junctional sequences from the construct. With only one exception (the #5 band), all other junctional bands had deletions, which
are marked by dotted lines between the solid lines. The solid lines represent the detected sequences. The position of the junctions is marked with
negative numbers for the fragment on the left and positive numbers for the fragment on the right.
doi:10.1371/journal.pone.0018778.g002
Figure 3. Increased apoptosis in the proliferating cell population in prenatal mouse brains. Embryos of the double transgenic and wild
type mice at different stages from line miR-PGRN9 were fixed and frozen brain sections were cut 10 mm thick. The sections from 13.5 dpc (days post
coitum) and 14.5 dpc were stained for activated caspase 3 and the sections from 16.5 dpc were stained with TUNEL. The positive signal for apoptosis
was mostly observed around the ventricular zone in the double transgenic mice, as shown in the figure. Scale bar=200 mm.
doi:10.1371/journal.pone.0018778.g003
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express transgenes in mice in 1992 [1,2]. In recent years, the use of
loxP-containing transgenes in transgenic mice has increased but
the possibility of unintended effects of this approach has not been
taken into consideration [5,7,8,9,10,11,12,13,14,37,38,39,40,41].
Our data demonstrate that, contrary to the widely held
assumption that transgenes are integrated into the genome in a
head-to-tail tandem array [5,7,8,9,10,11,12,13,14,28,29,30,
37,38,39,40,41], inverted transgene integration is common when
multiple copies of the transgene are integrated into the genome.
Therefore, the non-specific effects of the inverted loxP sites have
been overlooked and can provide alternative interpretations to the
previous studies using this conditional transgene expression
strategy. For example, a mutant SOD1 transgene that was flanked
by loxP sites was used to construct a model for amyotrophic lateral
sclerosis (ALS), which was crossed with a P0-Cre driver line. It was
intended to delete the mutant SOD1 gene from the Schwann cells,
thereby diminishing the expression of the mutant SOD1 in this cell
type. The investigators observed that the ALS phenotype was
exacerbated and concluded that the SOD1 enzyme activity carried
by the mutant protein was protective to motor neurons and the
reduction of this activity was responsible for the observed result
[10]. Based on our result, an alternative interpretation is that
ablation of proliferating Schwann cells during development or
during axonal degeneration caused the observed phenotype. In
another case, the Cre-loxP strategy was used to conditionally
express shRNAs that silenced the fibroblast growth factor receptor
2( Fgfr2) gene. When the shRNA was ubiquitously induced by
EIIa-Cre driver, embryonic lethality was observed. When the
shRNA was induced in the limb bud of the mouse embryos, an
enhanced cell death and malformed limbs developed. The authors
attributed these effects to specific silencing of the Fgfr2 gene [7].
Based on our data, an alternative interpretation is that the non-
specific effects associated with the Cre-loxP approach caused the
observed phenotypes. In conclusion, it is imperative that
investigators who use transgenic lines constructed with loxP-
containing transgenes take the non-specific effect into consider-
ation in the experimental design and the interpretation of the
results.
Materials and Methods
Transgene constructs
A previously described pCAG-EGFP/RFP-miRNAint (G/R-
miRNA) construct [15] was used to construct the miRNA
expression transgenes (Fig. 1A). The pCAG-EGFP/RFP-miR-
E1k (miR-E1-1 in [15]) synthesizes a miRNA that targets the E1k
subunit of a ´–ketoglutarate dehydrogenase complex (KGDHC).
The pCAG-EGFP/RFP-miR-Scr synthesizes a scrambled miRNA
that targets no specific gene. These constructs were built as
described previously [15]. pCAG-EGFP/RFP-miR-Pgrn1 and 9
target the mouse progranulin gene and they were constructed as
follows: miRNAs were designed and inserted into the pCAG-
EGFP/RFP-miRNAint backbone as described previously [15].
The target sequence of miR-Pgrn1 is 59-GGACACAUGGCCUA-
GAAUAACGA-39. The target sequence of miR-Pgrn9 is 59-
TCCAGAGTAAGTGCCTATCCAA-39. All constructs were
verified by DNA sequencing. The constructs were tested for
knockdown efficiency in mouse NF-1 cells as described previously
[15] before being used for making transgenic mice.
Generation and propagation of transgenic mouse lines
The pCAG-EGFP/RFP-miRNAint constructs were linearized
by digestion with the restriction enzymes SspI and PciI. The
6.3 kb DNA fragment was isolated from agarose gel, further
purified using QIAquick Gel Extraction Kit (Qiagen) and injected
into C57BL/66SJL F2 hybrid mouse embryos by the Transgenic
Animal Modeling Core. All mice were maintained at the
University of Massachusetts Medical School animal facility
according to the guidelines set forth by the Institutional Animal
Care and Use Committee (IACUC) and all animal procedures
were approved by the IACUC (protocol A1044). Transgenic mice
were identified by a 365 bp fragment produced by PCR of
genomic DNA extracted from tails or ear clips using the primer
pair 59-AGTGGGAGCGCGTGATGAACTTCGA-39 and 59-
CTGCTCCACGATGGTGTAGTCCTCGT-39. The PCR pro-
gram is 2 minutes at 95uC, followed by 35 cycles of 95uC for
30 seconds, 65uC for 30 seconds, and 72uC for 30 seconds. The
transgenic mice were maintained as heterozygotes by crossing to
C57BL/6J mice.
To induce the miRNA expression in the central nervous system
(CNS), the conditional G/R-miRNA mice were crossed with
Nestin-Cre mice (stock #003771, Jackson Laboratory, Bar
Harbor, Maine, USA) to obtain the double transgenic mice (G/
R-miR;Nes-Cre). Analyses on the double transgenic mice were
carried out by comparing them with the wild type and single
transgenic littermates. For analysis of mouse embryos, timed
matings were carried out and the embryos were obtained from the
pregnant females at specified times after they were sacrificed by
isoflurane overdose.
Determination of transgene copy numbers and junctions
Transgene copy numbers were determined by quantitative
PCR. Genomic DNAs were extracted and purified from mouse
tails by DNeasy Blood & Tissue Kit (Qiagen) according to the
manufacturer’s instructions. To generate a standard curve, various
amounts of pCAG-EGFP/RFP-miRNAint plasmid DNA were
added to 396 pg of mouse genomic DNA (equivalent to 60 copies
of diploid DNA) from non-transgenic mouse tails at the ratios of 0,
1, 4, 16 and 64 copies per diploid genome. Real time PCR was
conducted on duplicates of this standard series and DNA samples
(396 pg each) from the transgenic lines using a primer pair 59-
CCGTGAAGCTGAAGGTGAC-39 and 59-ATCACGCGCT-
CCCACTTG-39, which amplifies a 150 bp fragment of the RFP
gene. For each reaction, an internal reference reaction was also
conducted using the primer pair 59-CTCTCTCCGTTGCAGG-
CAT-39 and 59-GTCTTACAGTGAGCTCCGTTC-3, which
amplifies a 195 bp fragment of the Fabpi gene. Quantitative
PCR was performed using IQ Sybr Green mix (Bio-Rad)
according to the manufacturer’s instructions. Program for PCR
was set as: 95uC for 3 minutes followed by 40 cycles of 95uC for
15 seconds and 57uC for 60 seconds. Melting curves were checked
to ensure a single peak. PCR products were run on a 2% agarose
gel to verify the DNA size. The Ct values were obtained from the
PCR data with the threshold set near the middle of the linear
range on a log scale. For each reaction, the DCt was calculated by
subtracting the Ct value of the reference gene Fabpi from the Ct
value of the transgene. The average DCt values were plotted
against log (transgene copy number) to generate a standard curve.
The transgene copy numbers were then derived from the standard
curve with the DCt values of the transgenic DNA samples.
To determine the transgene junctions, tail DNA samples were
prepared as described above. Primers were designed to detect
three types of junctions: tail-to-tail, head-to-head and head-to-tail
(Table 3). A regular PCR program was used for detection of the
head-to-tail junctions: 4 minutes at 95uC, followed by 35 cycles of
30 seconds at 95uC, 30 seconds at 60uC, and 30 seconds at 72uC.
A special PCR assay had to be implemented to detect the inverted
A Non-Specific Effect of Cre-loxP Strategy
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initial regular PCR assay failed to detect these junctions, which
was likely due to the potential for folding into hairpin structures by
these junctions during the PCR reaction. First, our primer pairs
were designed to form asymmetric PCR products that minimize
the folding potential for hairpins. For each primer pair, one
targeted the sequence near the junction while the other targeted
sequence farther from the junction. Second, sequences that were
not complementary to the transgene sequence were added to the
59 end of each primer (Table 3, sequences in parentheses). Third, a
two-stage PCR program was implemented. The first stage was
4 minutes at 95uC, followed by 4 cycles of 30 seconds at 95uC,
30 seconds at 51uC and 30 seconds at 72uC. This was followed by
the second stage: an additional 40 cycles of 30 seconds at 95uC,
30 seconds at 61uC, and 30 seconds at 72uC. The PCR products
were checked on a 2% agarose gel. The DNA bands were purified
with QIAquick Gel Extraction Kit (Qiagen) and sequenced to
verify that the fragments were derived from the transgene
junctions.
Quantification of the levels of mRNA and miRNA
Total RNA was extracted from mouse tissues by Trizol reagent
(Invitrogen) and treated with DNase I (Promega). For mRNA
quantification, cDNA was synthesized using SuperScript III kit
(Invitrogen) following the manufacturer’s protocol. Quantitative
PCR was performed by using IQ Sybr Green mix (Bio-Rad). The
primer pair 59- CTAAGGTTGGGAATGTGGAGT-39 and 59-
AAACATGTCCCAGCGAGGA-39 were designed for the mouse
progranulin gene with a product size of 209 bp. The primer pair
59-TTCACTCGGGTGGAGCTG-39 and 59-ATGAAACATTT-
TGTCCTGAAGC-39 were designed for the mouse E1k gene with
a product size of 65 bp. Mouse gene glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) was used as an internal reference and
was amplified with the primer pair 59-CTGGAGAAACCT-
GCCAAGTA-39 and 59-TGTTGCTGTAGCCGTATTCA-39,
which produced a PCR product of 223 bp. The PCR program
was set as follows: 3 minutes at 95uC, followed by 40 cycles of
15 seconds at 95uC, 30 seconds at 56uC, and 20 seconds at 72uC.
Ct values were derived from the PCR data with the threshold set
near the middle of the linear range on a log scale. DCt was
calculated by subtracting the Ct value of Gapdh from that of Pgrn
or E1k. DDCt values were derived by subtracting the DCt values of
the wild type from those of the single transgenic and double
transgenic mice, which were then used to calculate the levels of the
mRNA in the double transgenic mice as a percentage of the level
in the wild type mice.
For miRNA quantification, cDNA was synthesized using
QuantiMir Kit (System Biosciences) following the manufacturer’s
protocol. The universal reverse primer in the kit was used for all
the reactions. Specific forward primers were used for miR-pgrn-1
(59- TCGTTATTCTAGGCCATGTGTC-39), miR-pgrn-9 (59-
TTGGATAGGCACTTACTCTGG-39), miR-E1k (59-TTGA-
TGTGCAAGATCTTCTCAT-39), miR-Scr (59-TTGATAGA-
ACCTTAGAGCATCG-39) and mouse U6 (59-TGGCCC-
CTGCGCAAGGATG-39). The IQ Sybr Green mix (Bio-Rad)
was used for the PCR reactions. The PCR was programmed as
follows: 5 minutes at 95uC, followed by 40 cycles of 15 seconds at
95uC, 5 seconds at 56uC, and 5 seconds at 72uC. DCt values were
calculated by subtracting the Ct value of the U6 from that of
various miRNAs. DDCt values were derived by subtracting the
DCt of the wild type background level from the DCt of the single
transgenic and double transgenic mice, which were then used to
derive the fold increase of the miRNA over the wild type
background level. All the qPCR reactions were done on the
OPTICON system (MJ research).
Histological analysis
Adult mice under deep anesthesia were transcardially perfused
with cold PBS followed by cold fixation buffer containing 4%
paraformaldehyde in PBS. Tissues were immersed in the same
fixative overnight at 4uC. Mouse embryos were dip-fixed in the
fixative overnight at 4uC. After fixation, tissues were immersed in
PBS containing 15% sucrose for 2–3 days at 4uC. Tissues were
then frozen in OCT freezing media (Sakura, Torrance, CA) and
stored at 280uC. Frozen sections were cut at 10 mm using a
cryostat and air-dried on slides at room temperature for 1 hour.
For immunofluorescence staining, slides were incubated in the
blocking solution (5% normal goat serum, 0.2% Triton X-100, 2%
fat-free dry milk in PBS, pH 7.4) for 30 min at room temperature
(RT), rinsed three times in PBS, and incubated with a primary
antibody in the blocking solution overnight at 4uC. The slides were
then rinsed with PBS three times and incubated with a secondary
antibody in the blocking solution for 2 hrs at RT in dark. After
washing, the slides were mounted with Vectashield mounting
medium containing 49,69-diamidino-2-phenylindole (DAPI, Vec-
tor Laboratories). Images were taken using Nikon Eclipse Ti
microscope equipped with NIS elements software and the three-
dimensional deconvolution program Autoquant (Nikon). The
Table 3. PCR primers for detection of transgene junctions.
Junction type Primer Primer sequence
Head-to-tail XF1 59-CAGAAGGTGGTGGCTGGTGTG-39
XR1 59-TGGCGTTACTATGGGAACATACGT-39
Head-to-head 5F1 59-(ACCGCCA)CGTAAGTTATGTAACGCGGAAC-39
5R1 59-(GCGAGTGTCGTG)GACAATAACCCTGATAAATGCTTCAATA-39
5R2 59-(CAACGCCAC)CTCATGAGACAATAACCCTGATAAATG-39
Tail-to-tail 3F1 59-(ACGAATAGCCGA)CTGGCTGCCATGAACAAAG-39
3F2 59-(GTCCTCCGACA)TCACTCGGAAGGACATATGG-39
3R1 59-(AGCCCAGTGCCC)TTTTTTCTTTAACATCCCTAAAATTTTCCTTA-39
3R2 59-(CGCAGTGCCC)GTTATTTTTTTCTTTAACATCCCTAAAATTTTCC-39
3R2 59-(CGAGTGCCG)GTTTTGTGTTATTTTTTTCTTTAACATCCCTA-39
Sequences in the parentheses were intentionally designed not to match with the transgene. See Materials and Methods for details.
doi:10.1371/journal.pone.0018778.t003
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mouse Caspase 3 active antibody (R&D systems, AF835), Alexa
Fluor 568-conjugated goat anti-rabbit IgG (Invitrogen). For
terminal deoxynucleotidyl transferase dUTP-X nick end labeling
(TUNEL) to detect 39-hydroxy termini of DNA strand breaks,
frozen sections were prepared as stated above and proceeded using
an In Situ Cell Death Detection kit (Roche) according to the
manufacturer’s instructions. Routine Hematoxylin and Eosin
staining (H&E) was performed by Univeristy of Massachusetts
Medical School DERC morphology core.
Statistics
Statistical analysis of Mendelian ratio was done using Chi
Square method (Table 2). Brain weight comparisons between the
double transgenic and the wild type were done using Student’s t-
test (Table S1).
Supporting Information
Table S1 The weights are in grams (Mean6SD). Values from
the double transgenic mice were compared with the wild type mice
using Student’s t test. The numbers in parentheses indicate the
number of animals.
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